We are live on ! Find out more
FRM

Fox Run Management Portfolio holdings

AUM $572M
1-Year Est. Return 24.16%
This Fund
S&P 500
This Quarter Est. Return
+1.23%
1 Year Est. Return
+24.16%
3 Year Est. Return
+44.85%
5 Year Est. Return
+32.84%
10 Year Est. Return
+244.98%
AUM
$551M
AUM Growth
+$101M
Cap. Flow
+$114M
Cap. Flow %
20.73%
Top 10 Hldgs %
5.17%
Holding
1,228
New
467
Increased
212
Reduced
149
Closed
400

Sector Composition

Rank Sector Weight
1 Technology 20.95%
2 Industrials 14.75%
3 Consumer Discretionary 12.92%
4 Healthcare 11.68%
5 Financials 11.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TLK icon
726
Telkom Indonesia
TLK
$14.2B
$227K 0.04%
13,774
-159
-1% -$2.78K
ELV icon
727
Elevance Health
ELV
$81.9B
$225K 0.04%
611
-574
-48% -$240K
GDYN icon
728
Grid Dynamics Holdings
GDYN
$476M
$223K 0.04%
+10,010
New +$175K
HWM icon
729
Howmet Aerospace
HWM
$116B
$222K 0.04%
+2,029
New +$222K
MOH icon
730
Molina Healthcare
MOH
$10.3B
$221K 0.04%
761
-1,419
-65% -$438K
HIG icon
731
Hartford Financial Services
HIG
$38.5B
$221K 0.04%
+2,022
New +$234K
WCC
732
WESCO International
WCC
$16.2B
$221K 0.04%
1,220
-1,970
-62% -$372K
BAC icon
733
Bank of America
BAC
$435B
$219K 0.04%
+4,973
New +$219K
TENB icon
734
Tenable Holdings
TENB
$3.56B
$218K 0.04%
+5,525
New +$229K
PPLI
735
People Inc
PPLI
$3.1B
$217K 0.04%
+6,145
New +$246K
ANF icon
736
Abercrombie & Fitch
ANF
$4.17B
$216K 0.04%
1,448
-6,642
-82% -$970K
SNDX icon
737
Syndax Pharmaceuticals
SNDX
$1.84B
$216K 0.04%
16,355
-13,601
-45% -$233K
HCAT icon
738
Health Catalyst
HCAT
$154M
$216K 0.04%
+30,576
New +$244K
PLNT icon
739
Planet Fitness
PLNT
$4.23B
$215K 0.04%
+2,173
New +$198K
CHE icon
740
Chemed
CHE
$6.78B
$213K 0.04%
402
-271
-40% -$153K
CCJ icon
741
Cameco
CCJ
$38.3B
$212K 0.04%
4,132
-193
-4% -$10.5K
INN
742
Summit Hotel Properties
INN
$761M
$212K 0.04%
30,956
+15,814
+104% +$104K
ARDX icon
743
Ardelyx
ARDX
$1.24B
$211K 0.04%
41,531
+28,324
+214% +$156K
AVXL icon
744
Anavex Life Sciences
AVXL
$222M
$210K 0.04%
+19,568
New +$151K
RXRX icon
745
Recursion Pharmaceuticals
RXRX
$1.57B
$210K 0.04%
+31,078
New +$209K
PAG icon
746
Penske Automotive Group
PAG
$14.3B
$210K 0.04%
+1,378
New +$219K
DOMO icon
747
Domo
DOMO
$166M
$210K 0.04%
+29,647
New +$240K
BHVN icon
748
Biohaven
BHVN
$2.16B
$210K 0.04%
+5,611
New +$262K
PM icon
749
Philip Morris
PM
$301B
$209K 0.04%
+1,738
New +$219K
FL
750
DELISTED
Foot Locker
FL
$208K 0.04%
9,571
-5,261
-35% -$123K

Similar funds

Fox Run Management's Q4 2024 Portfolio in Review

As of Q4 2024, Fox Run Management held 1,228 positions worth $551M, up 23% from $449M the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.

Fox Run Management deployed $114M of net new capital in Q4 2024, opening 467 new positions and adding to 212 existing holdings. Its largest new stake was State Street Financial Select Sector SPDR ETF: 111,700 shares worth $5.4M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was BILL Holdings, an estimated $1.94M trimmed.

  • Fox Run Management's largest Q4 2024 buy was State Street Financial Select Sector SPDR ETF: 111,700 shares worth $5.4M.
  • Fox Run Management added most to iShares US Real Estate ETF in Q4 2024, an estimated $3.75M increase.
  • Fox Run Management's biggest Q4 2024 reduction was BILL Holdings, cutting an estimated $1.94M.
  • Fox Run Management fully exited State Street SPDR S&P 500 ETF Trust in Q4 2024, selling an estimated $4.21M.
  • Fox Run Management's ten largest holdings make up 5.2% of its $551M portfolio in Q4 2024.
  • Fox Run Management opened 467 new positions and closed 400 in Q4 2024.
  • Fox Run Management's portfolio value rose 23% quarter-over-quarter to $551M.

Based on Fox Run Management's 13F filing for Q4 2024, filed 11 Feb 2025.